A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays

A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays

ABSTRACT The emergence of SARS-CoV-2 created a crucial need for serology assays to detect anti-SARS-CoV-2 antibodies, which led to many serology assays entering the market. A trans-government collaboration was created in April 2020 to independently evaluate the performance of commercial SARS-CoV-2 s...

Full description

Bibliographic Details
Main Authors: Ligia A. Pinto, Ribhi M. Shawar, Brendan O’Leary, Troy J. Kemp, James Cherry, Natalie Thornburg, Cheryl N. Miller, Pamela S. Gallagher, Timothy Stenzel, Brittany Schuck, S. Michele Owen, Marina Kondratovich, Panayampalli S. Satheshkumar, Amy Schuh, Sandra Lester, M. Cristina Cassetti, Norman E. Sharpless, Steven Gitterman, Douglas R. Lowy
Format: Article
Language:English
Published: American Society for Microbiology 2022-02-01
Series:Microbiology Spectrum
Subjects:
Emergency Use Authorization
SAR-CoV-2
serology assay
evaluation panel
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01564-21

Internet

https://journals.asm.org/doi/10.1128/spectrum.01564-21

Similar Items